Presented on: August 14, 2020
MRCT Center Faculty Director Dr. Barbara E. Bierer had a thoughtful and informative discussion on Sree Sreenivasan‘s Daily, Global Show discussing COVID Clinical Trials and the need for diversity in clinical research.
Focus Area: Clinical Trials & Research
Dr. Barbara Bierer is a guest on the Sree Sreenivasan Daily, Global Show podcast
Podcast
Presented on: August 14, 2020
MRCT Center Faculty Director Dr. Barbara E. Bierer had a thoughtful and informative discussion on Sree Sreenivasan‘s Daily, Global Show discussing COVID Clinical Trials and the need for diversity in clinical research.
Rethinking ethical oversight in the era of the learning health system
Publication
Published on: August 6, 2020
Published in: Healthcare: The Journal of Delivery Science and Innovation
The MRCT Center Announces Newly Published Guidance Addressing Achieving Diversity, Inclusion, and Equity in Clinical Research
The MRCT Center announces the release of The MRCT Center’s Achieving Diversity, Inclusion, and Equity in Clinical Research Guidance Document, accompanied with practical resources, tools, and case studies, available to download.
Read the Brigham and Women’s Hospital press release >
Diversity, Inclusion, and Equity In Clinical Research: Diversity Principles And Suppositions
Framework
Developed on: August 2020
Developed by: MRCT Center Diversity Workgroup
The MRCT Center Diversity Workgroup has developed a set of fundamental principles that help to frame considerations of diverse representation in clinical research. While we recognize that a case-based analysis will be required for each clinical research question, we also believe that these principles will help guide those analyses.
Action for Change: Diversity, Inclusion, and Equity in Clinical Research.
Framework: Action For Change
Developed on: August 2020
Developed by: MRCT Center Diversity Workgroup
There are practical and operational barriers that prevent routine participation of underrepresented, underserved, and diverse populations in clinical research. These must be addressed to promote change. While many challenges exist, for each section, we provide a key summary and recommendations to address appropriate representation in clinical research. Link to Resource >
Response to the FDA’s RFI on Rare Disease Clinical Trial Networks, supporting the Rare Disease Cures Accelerator
Public Comments
Comments provided on: July 20, 2020
Comments provided to: Food and Drug Administration (FDA)
Response to FDA’s request for comments on strategic priorities for the Office of Minority Health and Health Equity (OMHHE)
Public Comments
Comments provided on: June 29, 2020
Comments provided to: Food and Drug Administration (FDA)
Mark Barnes co-authors a special report in New England Journal of Medicine
Mark Barnes, MRCT Center Faculty Co-Director co-authored a special report in New England Journal of Medicine “Challenges of “Return to Work” in an Ongoing Pandemic.”
Observational Patient Evidence for Regulatory Approval and understanding Disease (OPERAND)
Presentation
Presented on: June 18, 2020
Presented by: Barbara E. Bierer, MD
Presented at: DIA 2020 Virtual Global Annual Meeting